In a slow news last week a mixed batch of clinical trials results featured. First, US biotech Ultragenyx announced ...

US gastrointestinal (GI) and rare diseases specialist has announced financial guidance for full year 2026, which pleased ...

US pharma major Pfizer (NYSE: PFE) has reported the death of a participant enrolled in a long-term extension study of its ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Kostaive (zapomeran) mRNA COVID-19 ...

US biotech Ultragenyx Pharmaceutical In this week revealed that it has completed the rolling submission of its Biologics ...

China-based Insilico Medicine, an AI-driven drug discovery and a portfolio company of Qiming Venture Partners, has ...

US biotech Corcept Therapeutics (Nasdaq: CORT) said the American medicines regulator has issued a complete response letter ...

China’s Zelgen Pharma has entered into a strategic collaboration and license option agreement with US pharma major AbbVie for ...

The US Food and Drug Administration (FDA) has accepted for filing Axsome Therapeutics’ supplemental New Drug Application (NDA ...

German drug discovery company Evotec (Nasdaq: EVO) has announced the appointment of Dr Sarah Fakih as executive vice ...

Indian pharma major Lupin Limited announced that it has entered into an exclusive license, supply and distribution agreement ...

US biopharma company Greenwich LifeSciences has announced an 80% reduction in breast cancer recurrence from its ongoing Phase ...